GYNIX Drug Patent Profile
✉ Email this page to a colleague
When do Gynix patents expire, and when can generic versions of Gynix launch?
Gynix is a drug marketed by Teva Pharms and is included in one NDA.
The generic ingredient in GYNIX is clotrimazole. There are eleven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gynix
A generic version of GYNIX was approved as clotrimazole by P AND L on July 16th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GYNIX?
- What are the global sales for GYNIX?
- What is Average Wholesale Price for GYNIX?
Summary for GYNIX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 126 |
| Patent Applications: | 3,479 |
| DailyMed Link: | GYNIX at DailyMed |
US Patents and Regulatory Information for GYNIX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms | GYNIX | clotrimazole | TABLET;VAGINAL | 073249-001 | Feb 13, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
